The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of ...

How can altering DNA help defeat one of the world’s deadliest diseases? This video explores how scientists are using CRISPR ...

Both CRSP and NTLA are advancing in vivo gene editing therapies targeting large markets, with financial stability supporting ...

Seven years after the first gene-edited babies were revealed, biotech startup Manhattan Genomics is reviving the idea of ...

Arc Institute, Gladstone Institutes, and University of California, San Francisco, scientists have developed an epigenetic ...

We have the tech to make designer babies but we are not ready for it yet. Read more at straitstimes.com. Read more at straitstimes.com.

Samsung Group said Thursday it will invest in Arbor Biotechnologies, a US-based gene editing company, through its Life ...

Arc Institute, Gladstone Institutes, and University of California, San Francisco, scientists have developed an epigenetic ...

In a significant turn of events, Intellia Therapeutics has announced the temporary suspension of dosing and patient screening in two late-stage studies of its groundbreaking gene-editing treatment ...

Unlocking secrets from East Africa's naked mole rats, scientists are amazed by their cancer immunity and unique social ...

Researchers at the Centre for Genomic Regulation show that cancer doesn’t invent new tricks—it reawakens embryonic splicing ...

The press release will be available in the Investors section of Cellectis’ website: Cellectis will not host a conference call to discuss these results. Our investors relations team remains available ...